Stocks and Investing
Stocks and Investing
Fri, November 4, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Joseph Schwartz Maintained (AUPH) at Buy with Decreased Target to $12 on, Nov 4th, 2022
Joseph Schwartz of SVB Leerink, Maintained "Aurinia Pharmaceuticals Inc." (AUPH) at Buy with Decreased Target from $17 to $12 on, Nov 4th, 2022.
Joseph has made no other calls on AUPH in the last 4 months.
There is 1 other peer that has a rating on AUPH. Out of the 1 peers that are also analyzing AUPH, 0 agree with Joseph's Rating of Hold.
This is the rating of the analyst that currently disagrees with Joseph
- Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $26 on, Tuesday, August 9th, 2022
Contributing Sources